BNAZULXLJAEYGJ-UJFFWINMSA-N
C27H26BrF3N6O4S — CID 142420777
Data last refreshed: (MolForge compound catalog, from PubChem)
About BNAZULXLJAEYGJ-UJFFWINMSA-N
BNAZULXLJAEYGJ-UJFFWINMSA-N (PubChem CID 142420777) has the molecular formula C27H26BrF3N6O4S and a molecular weight of 667.51 g/mol. Its IUPAC name is (1R,3S,5R)-2-[2-[3-acetyl-7-[S-methyl-N-(2,2,2-trifluoroacetyl)sulfinimidoyl]indazol-1-yl]acetyl]-N-(6-bromo-3-methyl-2-pyridinyl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide.
Molecular Properties
| Compound Name | BNAZULXLJAEYGJ-UJFFWINMSA-N |
|---|---|
| PubChem CID | 142420777 |
| Molecular Formula | C27H26BrF3N6O4S |
| Molecular Weight | 667.51 g/mol |
| Exact Mass | 666.09 |
| IUPAC Name | (1R,3S,5R)-2-[2-[3-acetyl-7-[S-methyl-N-(2,2,2-trifluoroacetyl)sulfinimidoyl]indazol-1-yl]acetyl]-N-(6-bromo-3-methyl-2-pyridinyl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide |
| SMILES | CC(=O)c1nn(CC(=O)N2[C@H](C(=O)Nc3nc(Br)ccc3C)C[C@@]3(C)C[C@@H]23)c2c(/S(C)=N/C(=O)C(F)(F)F)cccc12 |
| InChI | InChI=1S/C27H26BrF3N6O4S/c1-13-8-9-19(28)32-23(13)33-24(40)16-10-26(3)11-18(26)37(16)20(39)12-36-22-15(21(34-36)14(2)38)6-5-7-17(22)42(4)35-25(41)27(29,30)31/h5-9,16,18H,10-12H2,1-4H3,(H,32,33,40)/t16-,18+,26-,42?/m0/s1 |
| InChIKey | BNAZULXLJAEYGJ-UJFFWINMSA-N |
| XLogP | 4.60 |
| TPSA | 126.62 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 667.51 |
| LogP ≤ 5 | 4.60 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142420777 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.